Examination Report |
1 | TM-1 | 27 Aug 2015 |
10 | TM-R(RENEWAL OF TRADE MARK) | 02 Nov 2024 |
2 | MIS-A | 02 Sep 2015 |
3 | Reply to Exam Report (MIS-R) | 29 Sep 2016 |
4 | Affidavit | 12 Jul 2018 |
5 | Affidavit | 12 Jul 2018 |
6 | Journal Copy | 22 Oct 2018 |
7 | Certificate | 17 Jan 2019 |
8 | TM-M(CERTIFICATIE OF REGISTER (U/S 137) / CERTIFIED COPY OF A DOCUMENT) | 02 May 2019 |
9 | TM-M(CERTIFICATIE OF REGISTER (U/S 137) / CERTIFIED COPY OF A DOCUMENT) | 22 May 2019 |
1 | Dispatching of Examination Report for : 3042543 | 3765374 | 1864441 | 18 Jul 2016 |
2 | Hearing Notice (Show Cause) | 6442958 | 2970671 | 30 May 2018 |
3 | Hearing Notice (Adjourned) | 6662691 | 3098285 | 13 Jul 2018 |
4 | Tribunal Accepted Notice for : 3042543 | 6852181 | 3123658 | 20 Aug 2018 |
5 | RENEWAL INTIMATION LETTER | 19100354 | 05 Nov 2024 |
Trademark was applied on 27 August 2015 with IP India.
Proprietor of Stanlip is SUN PHARMACEUTICAL INDUSTRIES.
Class(es) in which the trademark was applied to is 5.
Status of Stanlip is Registered.
Application number alloted to the trademark is 3042543.
Trademark has been filed in the following category:
WORD